A major breakthrough in cancer study is arising with the use of VHH fragments to re-engage dysfunctional p53. This vital tumor inhibitor protein is frequently lost in several kinds of malignancies, leading uncontrolled https://bookmarkplaces.com/story21862352/mini-antibodies-revive-the-p53-protein-the-promising-pathway-for-malignant-management